DrugPricing

President Donald J. Trump revealed a new arrangement with pharmaceutical giants Eli Lilly and Novo Nordisk that will dramatically reduce the cost of their best‑selling obesity treatments. Under the deal, the monthly price for the drugs—currently marketed as some of the most effective options for weight loss and diabetes management—will be capped...